Literature DB >> 862243

Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function.

G W Hunninghake, A S Fauci.   

Abstract

The effect of cyclophosphamide on the absolute numbers and function of alveolar macrophages following either in vitro or in vivo drug exposure was studied in the guinea-pig. Two separate regimens of in vivo cyclophosphamide administration (100 mg/kg/one dose or 20 mg/kg for 5 days) both of which produce identical decreases in each population of peripheral blood leucocytes 5 days after the initial injection did not produce anay change in alveolar macrophage numbers when compared to control values. Neither a brief exposure to CY in vitro nor a brief exposure in vivo (100 mg/kg/one dose) caused any change in cytotoxic effector function of alveolar macrophages using the PHA-induced and antibody-dependent cellular cytotoxicity assays against sheep erythrocyte targets. In contrast, the more prolonged in vivo exposure to CY (20 mg/kg for 5 days), produced a significant decrease in the killer cell function of these cells. Thus, this study demonstrates that different regimens of cyclophosphamide administration, although producing similar degrees of peripheral blood leucopenia can produce markedly different effects on the functional capabilities of alveolar macrophages without quantitatively decreasing the absolute numbers of these cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862243      PMCID: PMC1540946     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Immunological reactivity of the lung. I. A guinea pig model for the study of pulmonary mononuclear cell subpopulations.

Authors:  G W Hunninghake; A S Fauci
Journal:  Cell Immunol       Date:  1976-09       Impact factor: 4.868

2.  Immunological reactivity of the lung II. Cytotoxic effector function of pulmonary mononuclear cell subpopulations.

Authors:  G W Hunninghake; A S Fauci
Journal:  Cell Immunol       Date:  1976-09       Impact factor: 4.868

Review 3.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Wegener's granulomatosis: studies in eighteen patients and a review of the literature.

Authors:  A S Fauci; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

5.  Management of fever of unknown origin in patients with neoplasms and neutropenia.

Authors:  V Rodriguez; M Burgess; G P Bodey
Journal:  Cancer       Date:  1973-10       Impact factor: 6.860

6.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

7.  Alterations in the bactericidal capacity of the rat lung after immunosuppression.

Authors:  R J Sharbaugh; J B Grogan
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

Review 8.  Cyclophosphamide: use in practice.

Authors:  M E Gershwin; E J Goetzl; A D Steinberg
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

9.  Fever in the neutropenic patient.

Authors:  K Atkinson; H E Kay; T J McElwain
Journal:  Br Med J       Date:  1974-07-20

10.  Pokeweed mitogen-, concanavalin A-, and phytohemagglutinin-induced development of cytotoxic effector lymphocytes. An evaluation of the mechanisms of T cell-mediated cytotoxicity.

Authors:  H Kirchner; R M Blaese
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  2 in total

1.  Characterization of a cyclophosphamide-induced murine model of immunosuppression to study Acinetobacter baumannii pathogenesis.

Authors:  Swetha Manepalli; Jay A Gandhi; Vaibhav V Ekhar; Melissa B Asplund; Carolina Coelho; Luis R Martinez
Journal:  J Med Microbiol       Date:  2013-09-02       Impact factor: 2.472

2.  T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  Christopher D Hammerbeck; Jay W Hooper
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.